<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Adapalene: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Adapalene: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Adapalene: Drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_patient" data-topicid="12448" href="/d/html/12448.html" rel="external">see "Adapalene: Patient drug information"</a> and <a class="drug drug_pediatric" data-topicid="13093" href="/d/html/13093.html" rel="external">see "Adapalene: Pediatric drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F130549"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Differin;</li>
<li>Differin [OTC]</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52865559"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Differin;</li>
<li>Differin XP</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F130576"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Acne Products;</li>
<li>
                        Retinoic Acid Derivative;</li>
<li>
                        Topical Skin Product, Acne</li></ul></div>
<div class="block doa drugH1Div" id="F130552"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a14813b8-cfac-43a7-8cfe-083e79bea0fc">Acne vulgaris</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Acne vulgaris:</b>
<b>Topical:</b> Cream 0.1%; Gel 0.1%, 0.3%; Lotion 0.1%: Apply once daily. Consider starting with the lowest possible concentration to minimize skin irritation and increase potency as tolerated. For moderate to severe acne, may be used as part of an appropriate combination regimen (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26897386']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26897386'])">Ref</a></span>). If irritation occurs, may reduce the frequency of application.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="cc3a2a3a-842f-4019-92f3-0d78d87a74b9">Rosacea</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Rosacea (off-label use):</b>
<b>Topical:</b> 0.1% Gel: Apply to affected area once daily in the evening for up to 12 weeks (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-15807740']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-15807740'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50989974"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; however, systemic absorption is not extensive, making the need for a dose adjustment unlikely.</p></div>
<div class="block doha drugH1Div" id="F50987309"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; however, systemic absorption is not extensive, making the need for a dose adjustment unlikely.</p></div>
<div class="block doe drugH1Div" id="F130553"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block dop drugH1Div" id="F130565"><span class="drugH1">Dosing: Pediatric</span><p>(For additional information <a class="drug drug_pediatric" data-topicid="13093" href="/d/html/13093.html" rel="external">see "Adapalene: Pediatric drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8fcccce5-b022-4cc3-a9f0-e1e02943485b">Acne vulgaris, treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:0em;">
<b>Acne vulgaris, treatment:</b> Children ≥7 years and Adolescents: Limited data available in ages &lt;12 years (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23637225']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23637225'])">Ref</a></span>): Topical: Apply once daily; cream, gel, or solution should be applied in the evening (at bedtime). <b>Note:</b> During the initial 2 weeks of therapy, it may appear that acne worsens; full effect may take up to 8 to 12 weeks of therapy.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51063306"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; however, dosage adjustment unlikely necessary due to low systemic absorption.</p></div>
<div class="block dohp drugH1Div" id="F51063307"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; however, dosage adjustment unlikely necessary due to low systemic absorption.</p></div>
<div class="block adr drugH1Div" id="F130532"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Adverse reactions reported in adolescents and adults.</p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%: Dermatologic: Burning sensation of skin (≤29%), erythema of skin (≤38%), exfoliation of skin (≤44%), pruritus (≤21%), stinging of the skin (≤29%), xeroderma (≤45%)</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%: Dermatologic: Skin irritation (≤2%), skin pain (discomfort; ≤2%), sunburn (≤2%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Acne flare, dermatitis (including contact dermatitis), eczema, skin discoloration, skin rash</p>
<p style="text-indent:-2em;margin-left:4em;">Ophthalmic: Conjunctivitis, eyelid edema</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Anaphylaxis, angioedema, facial edema, swelling of lips</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Application-site pain</p></div>
<div class="block coi drugH1Div" id="F130541"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to adapalene or any component of the formulation.</p>
<p style="text-indent:-2em;margin-left:2em;">OTC labeling: When used for self-medication, do not use on damaged skin (cuts, abrasions, eczema, sunburn).</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>Canadian labeling:</i> Additional contraindications (not in US labeling): Patients with eczema or seborrheic dermatitis; women who are pregnant or planning to become pregnant.</p></div>
<div class="block war drugH1Div" id="F130529"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Hypersensitivity reactions: Reactions such as anaphylaxis, angioedema, urticaria, pruritus, face edema, eyelid edema, and lip swelling have been reported. Discontinue use immediately if allergic or anaphylactoid/anaphylactic reactions occur.</p>
<p style="text-indent:-2em;margin-left:4em;">• Photosensitivity: Use is associated with increased susceptibility/sensitivity to UV light; avoid sunlamps or excessive sunlight exposure. Daily sunscreen use and other protective measures are recommended. Patients with sunburn should discontinue use until sunburn has healed.</p>
<p style="text-indent:-2em;margin-left:4em;">• Skin irritation: Certain cutaneous signs and symptoms such as erythema, dryness, scaling, stinging/burning, or pruritus may occur during treatment; these are most likely to occur during the first 2 to 4 weeks and will usually lessen with continued use. Treatment can increase skin sensitivity to weather extremes of wind or cold. Concomitant topical medications (eg, medicated or abrasive soaps and cleansers, or cosmetics with a strong drying effect, products with high concentrations of alcohol, astringents, spices or limes) should be avoided due to increased skin irritation. Depending on the severity of irritation, use moisturizer, reduce the frequency of application, or discontinue use.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: For external use only; avoid contact with abraded, broken, eczematous, or sunburned skin, mucous membranes, eyes, lips, and angles of the nose. Wax depilation is not recommended.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878313"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">May cause mild hyperglycemia; more common in pediatric patients. Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block foc drugH1Div" id="F130537"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Differin: 0.1% (45 g)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.1% (45 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Differin: 0.1% (15 g, 45 g); 0.3% (45 g) [contains edetate (edta) disodium, methylparaben, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Differin: 0.1% (15 g [DSC], 45 g) [fragrance free, oil free; contains edetate (edta) disodium, methylparaben, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.1% (15 g [DSC], 45 g); 0.3% (45 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Lotion, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Differin: 0.1% (59 mL) [contains methylparaben, propylene glycol, propylparaben]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Pad, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.1% (14 ea)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 0.1% (60 mL [DSC], 120 mL)</p></div>
<div class="block geq drugH1Div" id="F130525"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F130542"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Adapalene External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1% (per gram): $6.03 - $6.55</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Differin External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1% (per gram): $14.11</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Adapalene External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1% (per gram): $4.37</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.3% (per gram): $1.77 - $6.88</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Differin External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1% (per gram): $0.55</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.3% (per gram): $14.64</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Lotion</b> (Differin External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1% (per mL): $10.36</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Pads</b> (Adapalene External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1% (per each): $105.00</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Adapalene External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">0.1% (per mL): $8.80</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52865560"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Differin: 0.1% (2 g, 15 g, 45 g, 60 g) [contains edetate (edta) disodium, methylparaben, propylparaben, trolamine (triethanolamine)]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Differin: 0.1% (2 g, 15 g, 45 g, 60 g) [contains edetate (edta) disodium, methylparaben, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Differin XP: 0.3% (2 g, 60 g) [contains edetate (edta) disodium, methylparaben, propylene glycol]</p></div>
<div class="block adm drugH1Div" id="F13376045"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>Topical:</b> For topical use only; not for oral, ophthalmic, or intravaginal use. Avoid contact with abraded, broken, eczematous, or sunburned skin, mucous membranes, eyes, lips, and angles of the nose. Moisturizers may be used if necessary; avoid alpha hydroxy or glycolic acid-containing products. A mild transitory sensation of warmth or slight stinging may occur shortly after application.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Cream/gel:</b> Apply a thin film to face and other affected areas of the skin after washing with a mild, soapless, or nonmedicated cleanser in the evening before bedtime; apply enough to cover entire affected area.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>External pad:</b> Remove pad from foil just prior to use. Before bedtime, wash and dry area to be treated, then apply pad containing topical solution to affected areas. Discard pad after single use.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Lotion:</b> Apply a thin film after washing gently with a mild or soapless cleanser and then pat dry; dispense a nickel size amount (3 to 4 pump actuations) to cover entire face and other affected areas of the skin.</p></div>
<div class="block admp drugH1Div" id="F52612184"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Topical: For topical external use only. Avoid contact with eyes, angles of the nose, lips, and mucous membranes. Do not apply to cuts, abrasions, eczematous, or sunburned skin. Shortly after application, a mild transitory sensation of warmth or slight stinging may occur. Moisturizers may be used if necessary; avoid moisturizers containing alpha hydroxy or glycolic acid-containing products. Wash hands after application.</p>
<p style="text-indent:-2em;margin-left:2em;">Cream/gel: Cleanse affected area with a mild or soapless cleanser and pat dry; apply a thin film to skin in the evening before bedtime; apply enough to cover entire affected area.</p>
<p style="text-indent:-2em;margin-left:2em;">External pad: Remove pad from foil just prior to use. Before bedtime, wash and dry area to be treated, then apply pad containing topical solution to affected areas. Discard pad after single use.</p>
<p style="text-indent:-2em;margin-left:2em;">Lotion: Apply after washing gently with a mild or soapless cleanser and then pat dry; dispense a nickel size amount (3 to 4 pump actuations) to cover entire face.</p>
<p style="text-indent:-2em;margin-left:2em;">Solution: External Pad (Plixda): Remove pad from foil just prior to use. Before bedtime, wash and dry area to be treated, then apply pad containing topical solution to affected areas. Discard pad after single use.</p></div>
<div class="block use drugH1Div" id="F130538"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Acne vulgaris</b>: Treatment of acne vulgaris.</p></div>
<div class="block off-label drugH1Div" id="F25816099"><span class="drugH1">Use: Off-Label: Adult</span><p>Rosacea</p></div>
<div class="block cyt drugH1Div" id="F13298686"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F6217581"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Aminolevulinic Acid (Systemic): Photosensitizing Agents may enhance the photosensitizing effect of Aminolevulinic Acid (Systemic). <i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Aminolevulinic Acid (Topical): Photosensitizing Agents may enhance the photosensitizing effect of Aminolevulinic Acid (Topical). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Methoxsalen (Systemic): Photosensitizing Agents may enhance the photosensitizing effect of Methoxsalen (Systemic). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Multivitamins/Fluoride (with ADE): May enhance the adverse/toxic effect of Retinoic Acid Derivatives.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Multivitamins/Minerals (with ADEK, Folate, Iron): May enhance the adverse/toxic effect of Retinoic Acid Derivatives.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Multivitamins/Minerals (with AE, No Iron): May enhance the adverse/toxic effect of Retinoic Acid Derivatives.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Porfimer: Photosensitizing Agents may enhance the photosensitizing effect of Porfimer. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Verteporfin: Photosensitizing Agents may enhance the photosensitizing effect of Verteporfin. <i> Risk C: Monitor therapy</i></p></div>
<div class="block pri drugH1Div" id="F130543"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Outcome data following maternal use of adapalene during pregnancy are available (Autret 1997; Panchaud 2012; Weiss 2021).</p>
<p style="text-indent:0em;margin-top:2em;">In general, topical products are recommended for the treatment of acne in pregnancy due to lower systemic exposure. However, because adapalene may share the characteristic of teratogenicity with other retinoids, agents other than adapalene are preferred. Avoid applying large amounts over prolonged periods of time to decrease the potential for systemic absorption (Akhavan 2003; Kong 2013; Leechman 2006).</p></div>
<div class="block brc drugH1Div" id="F20519442"><span class="drugH1">Breastfeeding Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">It is not known if adapalene is present in breast milk.</p>
<p style="text-indent:-2em;margin-left:2em;">According to the manufacturer, the decision to breastfeed during therapy should consider the risk of infant exposure, the benefits of breastfeeding to the infant, and the benefits of treatment to the mother. The use of topical agents is generally preferred over systemic agents for the treatment of acne in patients who are breastfeeding. Topical adapalene may be compatible with breastfeeding; however, specific studies are not available. Avoid applying large amounts over prolonged periods of time to decrease the potential for systemic absorption (Kong 2013; Leechman 2006). Mothers should wash hands following application. Because topical agents can be transferred to a breastfeeding infant, avoid direct skin-to-skin contact with treated areas (Anderson 2018). Use of alternative agents or postponement of therapy may also be considered (Zip 2002).</p></div>
<div class="block pha drugH1Div" id="F130528"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Retinoid-like compound which is a modulator of cellular differentiation, keratinization, and inflammatory processes, all of which represent important features in the pathology of acne vulgaris</p></div>
<div class="block phk drugH1Div" id="F130540"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Onset of action: 8 to 12 weeks</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Absorption: Topical: Minimal; only trace amounts have been measured in serum after chronic application</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Half-life elimination, terminal: 7 to 51 hours (gel)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Excretion: Bile</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F130544"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Deriva | Differin | Surecure</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Acnidazil | Axne | Dermotopic | Differin | Doniq | Exogel | Panalene | Sinac</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Aclene | Adapel | Adgar | Apalene | Fona</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Adacne | Adapaleno | Adapel | Belpele | Dalap | Deriva micro | Differin</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Fona</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Adapac | Adapaleno | Adiamil | Daplen | Differin | Flamir | Nyskin | Zudenina</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Chu ya | Differin</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Adamac | Adapgel | Differin | Glenpalene | Zudenina | Zudenina f</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Belakne | Differine</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Differin | Differine | Dipalen</span>;</li>
<li>
<span class="countryCode">(DK)</span> <span class="country">Denmark</span><span class="countrySeparator">: </span><span class="drugName">Redap</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Adaferin | Adiamil | Deriva | Dicron | Panalene | Zudenina</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Adiamil | Deriva | Deriva gel aqueous | Dermotopic | Differin</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Acne Jed | Acnescave | Adagel | Adanoid | Aknapalen | Marpalene | Pal mash | Randapalene</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Differine</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">T3 ada</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Adapalene Dci | Adapalene Teva | Adapalene winthrop | Differine</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Adaferin</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Aclear | Acure | Differin | Ellia | Fona | Opalen</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Sona</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Evalen | Palenox</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Adaferin</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Aclene | Acneril | Adaclene | Adaferin | Adapen | Adaple | Adapnil | Adaret | Adiff | Aditop | Adlene | Adlene ad | Admark | Alangel | Alene | Ap | Apalene | Apgel | Deriva aqueous | Medapine | Opalen | Rozac</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Acne mafee | Differin | Surecure</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Adapalene iwaki | Adapalene jg | Adapalene nipro | Adapalene nissin | Adapalene tck | Adapalene teikoku | Adapalene toko | Adapalene yd | Differin</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Adapco | Fona | Klenzit</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Acferin | Aclea | Aclen | Adipolin | D2o | Differin | Dongkoo adapalene | Ellibel | Newcne</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Differine | Surecure</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Differin | Differine</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Differin | Differine</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Differin | Differine</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">Differine</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Adaferin | Bracitor | Leneda | Trabalene | Yunneco</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Deriva | Deriva ms | Differin | T3 ada</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Alviera | Andropalene | Deriva | Deriva ms | Differin | Ganaxin | Panalene</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Differin | Klenzit</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Aclene | Acne Lene | Acneris | Acnolin | Acpalene | Acpro | Adaferin | Adapal | Adapco | Adapco forte | Adapen | Adaplex | Adaptin | Adiff | Adlob | Aroleen | Arsodap | Clear | Clear cream | Clenac | Differin | Elucider | Gallet | Inapel | Pimpal | Semycin | Vee laar</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Acnelec | Differin</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Differin | Plixda</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Adapne | Adiamil | Differin | Sinac | Zudenina | Zudenina f</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Deriva | SureCure</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Adaclean | Adaklin | Adolen | Clenzit | Differin</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Adolin | Deriva | Differin | Surecure | Watene</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Belakne | Differin</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Belakne | Differine</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Differin</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Differine</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Acnefferin | Differin</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Acnely | Acure | Adagene T | Adalene | Adamei | Adarin | Adayung | Andopin | Anefree | Apalene | Beautyface | Differin | Easy acne | Feeling | Kwaie | Madyo | Maydo gel | Niffulene | Olena | Palene | Shinny | Tifforly</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Deriva gel aqueous</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Differin | Zudenina</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Adapne | Adiamil | Bioskin | Deriva aqueous | Differin | Zudenina</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Akneyash | Edithz</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Dapta | Deriva | Differin</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Acfree | Deriva</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Deriva</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-12814337">
<a name="12814337"></a>Adapalene Topical Solution (adapalene) [prescribing information]. Doylestown, PA: Rochester Pharmaceuticals; July 2021.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/12814337/pubmed" id="12814337" target="_blank">12814337</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12814337">
<a name="12814337"></a>Akhavan A, Bershad S. Topical acne drugs: review of clinical properties, systemic exposure, and safety. <i>Am J Clin Dermatol</i>. 2003;4(7):473-492.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/12814337/pubmed" id="12814337" target="_blank">12814337</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15807740">
<a name="15807740"></a>Altinyazar HC, Koca R, Tekin NS, Eştürk E. Adapalene vs. metronidazole gel for the treatment of rosacea. <i>Int J Dermatol</i>. 2005;44(3):252-255.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/15807740/pubmed" id="15807740" target="_blank">15807740</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>American Academy of Pediatrics Committee on Drugs. "Inactive" ingredients in pharmaceutical products: update (subject review). <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29298085">
<a name="29298085"></a>Anderson PO. Topical drugs in nursing mothers. <i>Breastfeed Med</i>. 2018;13(1):5-7.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/29298085/pubmed" id="29298085" target="_blank">29298085</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9251645">
<a name="9251645"></a>Autret E, Berjot M, Jonville-Bera AP, Aubry MC. Moraine C. Anophthalmia and agenesis of optic chiasma associated with adapalene gel in early pregnancy. <i>Lancet</i>. 1997;350(9074):339.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/9251645/pubmed" id="9251645" target="_blank">9251645</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26957383">
<a name="26957383"></a>Chien AL, Qi J, Rainer B, Sachs DL, Helfrich YR. Treatment of acne in pregnancy. <i>J Am Board Fam Med</i>. 2016;29(2):254-262.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/26957383/pubmed" id="26957383" target="_blank">26957383</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Differin and Differin XP (adapalene) [product monograph]. Thornhill, Ontario, Canada: Galderma Canada Inc; September 2021.</div>
</li>
<li>
<div class="reference">
                  Differin Cream (adapalene) [prescribing information]. Fort Worth, TX: Galderma; November 2011.</div>
</li>
<li>
<div class="reference">
                  Differin Gel 0.1% (adapalene) [prescribing information]. Fort Worth, TX: Galderma; June 2018.</div>
</li>
<li>
<div class="reference">
                  Differin Gel 0.3% (adapalene) [prescribing information]. Fort Worth, TX: Galderma; August 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Differin.5">
<a name="Differin.5"></a>Differin Lotion 0.1% (adapalene) [prescribing information]. Fort Worth, TX: Galderma; April 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23637225">
<a name="23637225"></a>Eichenfield LF, Krakowski AC, Piggott C, et al, "Evidence-Based Recommendations for the Diagnosis and Treatment of Pediatric Acne," <i>Pediatrics</i>, 2013, (131 Suppl 3):S163-86.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/23637225/pubmed" id="23637225" target="_blank">23637225</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23657872">
<a name="23657872"></a>Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and lactation. <i>Drugs</i>. 2013;73(8):779-787.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/23657872/pubmed" id="23657872" target="_blank">23657872</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16677965">
<a name="16677965"></a>Leachman SA, Reed BR. The use of dermatologic drugs in pregnancy and lactation. <i>Dermatol Clin</i>. 2006;24(2):167-197.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/16677965/pubmed" id="16677965" target="_blank">16677965</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22174426">
<a name="22174426"></a>Panchaud A, Csajka C, Merlob P, et al. Pregnancy outcome following exposure to topical retinoids: a multicenter prospective study.<i> J Clin Pharmacol.</i> 2012;52(12):1844-1851. doi:10.1177/0091270011429566<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/22174426/pubmed" id="22174426" target="_blank">22174426</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Plixda (adapalene) [prescribing information]. Charleston, SC: Marnel Pharmaceuticals; July 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34898146">
<a name="34898146"></a>Weiss J, Mallavalli S, Meckfessel M, Griffin S, Wagner N. Safe use of adapalene 0.1 % gel in a non-prescription environment. <i>J Drugs Dermatol</i>. 2021;20(12):1330-1335. doi:10.36849/jdd.6527<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/34898146/pubmed" id="34898146" target="_blank">34898146</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26897386">
<a name="26897386"></a>Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. <i>J Am Acad Dermatol</i>. 2016;74(5):945-973.e33. http://www.jaad.org/article/S0190-9622(15)02614-6/pdf. Accessed March 3, 2022.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/26897386/pubmed" id="26897386" target="_blank">26897386</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12007012">
<a name="12007012"></a>Zip C. Common sense dermatological drug suggestions for women who are breast-feeding. <i>Skin Therapy Lett</i>. 2002;7(3):5-7.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/adapalene-drug-information/abstract-text/12007012/pubmed" id="12007012" target="_blank">12007012</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 9352 Version 314.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
